Programme 12 February
08:15–08:45 Morning coffee meeting: Nordic Health Summit in Japan – Opportunities in the Japanese market
09:00–10:00 Norway, the Nordics and Europe: How to deliver tomorrow's healthcare?
In this session we will address the challenges we are facing in the healthcare system, showcase how health data and AI can be a tool in how to handle these challenges and discuss how to implement the innovation needed for the changes to happen.
Are the healthcare systems prepared to meet the challenges we are facing?
Malene Fisher, Research Director, Rigshospitalet, Denmark
Excellence in the Nordics brings solutions to the future healthcare
Case 1: How can health data and AI improve population health and inequities
Peter Speyer, Head of Data, Analytics & AI, Novartis Foundation
Case 2: Opportunities in AI-powered tools to predict personalized treatment to patients
Sigbj?rn Smeland, Head of Division, Oslo University Hospital
Panel discussion: The challenge of changing the healthcare system
- Saliba Andreas Korkunc, Vice Mayor for Health, Oslo
- Cathrine Lofthus, Secretary General, Ministry of Health and Care Services
- Trygve Ottersen, Director General, Norwegian Medical Products Agency
- Peter Speyer, Head of Data, Analytics & AI, Novartis Foundation
- Malene Fisher, Research Director, Rigshospitalet, Denmark
Moderator:
Bente Mikkelsen, Oslo Science City
Event organizer: LMI (Association of Pharmaceutical Industry in Norway)
10:00–11:00 Norway, Nordics, Europe - Research-driven innovation
The need for new solutions in health is enormous, and Norway and the Nordic countries have strong research base in the field. Can we contribute to increased innovation in life sciences and health?
Norwegian policy for the health industry
Keynote by
Cecilie Myrseth, Minister of Trade and Industry
Photo: Ministry of Trade, Industry and Fisheries
A need for an ambitious strategy for the Life Sciences
Presentation of the Danish life science strategy towards 2030
Ida Sofie Jensen, CEO LIF Denmark
An investment perspective on the European competitiveness in the life sciences
Friedemann Janus, SVP, Head of Business Development & Licensing, Co.Lab, Regional and Divestitures, Bayer
Panel discussion: Are we prepared to do what it takes to succeed?
According to a quote attributed to Albert Einstein, the definition of insanity is doing the same over and over again and expecting different results. What do we need to do differently to increase innovation and value creation, and do we have the will to do what is needed?
Photo Stensland: Parliament. Photo: Niederback: Agnete Brun.
-
Sveinung Stensland, Member of the Parliament, Conservative Party
-
Ida Sofie Jensen, CEO LIF Danmark
-
Svein St?len, Rector, University of Oslo
-
Per Niederbach, Head of Division, Innovation Norway
-
Ulf Landegren, Professor, Uppsala University
- Leif Rune Skymoen, General Manager, LMI
Moderator:
Idar Kreutzer, Area Director, NHO
Event organizer: LMI (Association of Pharmaceutical Industry in Norway)
11:00–12:30 Young Talents Inspirational Talks
11:00–11:20 Break
11:20–12:30 Parallel Sessions
Precision Medicine and Diagnostics – Evolving for Future Applications
This session explores current applications and future potential for precision medicine and diagnostics, highlighting recent innovations and advancements.
- Automatically AI Generated Liver and Heart Hologram for Surgical Planning and Guidance
?smund A. Fretland, Consultant, Henrik Brun, Consultant Pediatric Cardiologist and Postdoc Researcher, and Ole Jakob Elle, Professor/Group Leader Oslo University Hospital - Implementing Precision Cancer Medicine into Public Health Care Systems in Europe
Live Fagereng, Project Manager of the EU-project PRIME-ROSE and Coordinator, OUS Centre for Precision Cancer Medicine
- Next-Gen Diagnostics for Next-Gen Therapies in Cancer
?smund Flobak, Associate professor, NTNU, Senior researcher at SINTEF and Consultant Oncologist The Cancer Clinic, St. Olav’s Hospital - NeoMedSys – a Platform for Bringing Medical AI to the Clinic for Tomorrow’s Precision Medicine
Atle Bj?rnerud, Professor University of Oslo & Group Leader, Oslo University Hospital - AI Integration in the Pharmaceutical Industry: Advancements in Precision Medicine and Oncology Drug Development
Hege Edvardsen, Medical lead Oncology, GSK Norway and Co-Chair CONNECT Public-Private Partnership
Chair: Kjetil Taskén, Head Institute for Cancer Research, Oslo University Hospital & Professor University of Oslo
Event organizer: Oslo University Hospital, Oslo Cancer Cluster and SINTEF
Health Data and AI for Sustainable Healthcare
This session emphasizes the transformative potential of AI and data-driven insights in shaping a resilient and sustainable healthcare system.
- Real-World Health Data from Hospitals – Important for Quality and Research
?slaug Helland, Professor, Group leader, Oslo University Hospital - Digital Twins in Healthcare: Freeing Up Time for Patient Care in Hospital Wards
Frode Strisland, Senior Research Scientist, SINTEF Digital & and Assoc. Professor, University of Oslo - A Clinical Trial with AI in Early Stage Colorectal Cancer
Andreas Kleppe, Researcher, Oslo University Hospital - Pan-Cancer Tumour Segmentation with Deep Learning
Ole-Johan Skrede, Head Engineer, Oslo University Hospital -
Accelerating vaccine design through Deep Learning and B-Cell epitope predictions
Ioannis Vardaxis, Data Scientist, B-Cell Project Manager, NEC OncoImmunity and Matheus Ferraz, Structural Bioinformatician, NEC Bio Therapeutics
Chair: Morten Dalsmo, Executive Vice President, Customers and Market, SINTEF
Event organizer: SINTEF, Norway Health Tech and Oslo University Hospital
Technology outlook – the future of AI and robotics for the health sector
The session will have presentations covering major opportunities and challenges for the use of AI in the health sector.
- When will a robot treat us instead of a medical doctor?
Jim T?rresen, Professor, University of Oslo - Can a large language model predict the efficacy of a treatment for individual patients
Simen Eide, AI developer and researcher, Nordic RWE and Kristian Svendsen, Pharmacoepidemiologist, Nordic RWE - The near future of machine learning and how this could impact your health
Alvaro K?hn Luque, Senior Researcher and Valeria Vitelli, Associate Professor, University of Oslo - How AI engineering will be a crucial to succeed with integrating AI models into the large and complex IT systems of the health sector Antonio Martini, Professor, University of Oslo
- On the path to industrial use of Quantum Computers, and how can it impact healthcare and life science
Lars Nordbryhn, IBM Quantum Ambassador, IBM
Chair: Geir Kjetil Sandve, Professor, University of Oslo
Event organizer: dScience
12:30–13:30 Lunch
13:30–15:00 Afternoon Sessions
BioInnovation Institute: What our first 100 academic founders taught us about entrepreneurship
Bobby Soni, Chief International Officer, BioInnovation Institute, Copehagen
Photo: BioInnovation Institute & Esben Z?llner Olesen.
Pitching Session
Join when startup companies and innovation projects pitch their business idea.
- Klyv Therapeutics
Maria Vistnes, CEO - DoMore Diagnostics
Torbj?rn Furuseth, CEO - Epi-transcriptomic Anti-Cancer Drug Development
Adam Filipczyk, Project Group Leader, Oslo University Hospital - DuctMimic
Henry Hoyle, CEO - Augere Medical
Jon Hoem, CEO - AKIGAI
Christian Kersten, CEO
Panel:
- Torunn Wendel, Business Unit Head, GSK
- Nina Aalén D?rre, VP, CMC Radiopharm Lead, Bayer
- Jamie Cameron, Head of Medical Affairs, Novo Nordisk
Host: Morten Egeberg, Leader SPARK Norway and Administrative Leader UiO:Life Science
Young Talents Network Meetings
You will have the opportunity to meet representatives from companies.
Note that you need to register for Network meetings in order to attend (same registration form).
Go to the programme